AU2002341883A1 - 3-(heteroarylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors - Google Patents

3-(heteroarylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors

Info

Publication number
AU2002341883A1
AU2002341883A1 AU2002341883A AU2002341883A AU2002341883A1 AU 2002341883 A1 AU2002341883 A1 AU 2002341883A1 AU 2002341883 A AU2002341883 A AU 2002341883A AU 2002341883 A AU2002341883 A AU 2002341883A AU 2002341883 A1 AU2002341883 A1 AU 2002341883A1
Authority
AU
Australia
Prior art keywords
heteroarylamino
indol
dihydro
methylene
ones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002341883A
Inventor
Steven W. Andrews
Julie A. Wurster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of AU2002341883A1 publication Critical patent/AU2002341883A1/en
Abandoned legal-status Critical Current

Links

AU2002341883A 2001-09-27 2002-09-27 3-(heteroarylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors Abandoned AU2002341883A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60/325,816 2001-09-27
US60/325,817 2001-09-27

Publications (1)

Publication Number Publication Date
AU2002341883A1 true AU2002341883A1 (en) 2003-04-07

Family

ID=

Similar Documents

Publication Publication Date Title
WO2003035617A3 (en) Derivatives of uk-2a
AP2003002836A0 (en) 3-(4-Amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors.
AU2002303892A1 (en) 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
AU2003271566A1 (en) Pyrrolopyrazines as kinase inhibitors
AU2003249442A1 (en) Kinase inhibitors
AU2003222055A1 (en) Kinase inhibitors
AU2002305260A1 (en) Pyrazole derived kinase inhibitors
AU2003275282A1 (en) Novel tyrosine kinase inhibitors
AU2002253000A1 (en) Inflammation-inhibiting compounds
AU2003212310A1 (en) (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors
AU2003282804A1 (en) 3-(3,5-disubstituted-4-hydroxyphenyl)propionamide derivatives as cathepsin b inhibitors
AU2002304853A1 (en) Substituted benzopyranones as telomerase inhibitors
AU2002323406A1 (en) Tyrosine kinase inhibitors
AU2003269949A1 (en) Substituted 1,4-pyrazine derivatives
AUPR376201A0 (en) Voip communication
AU2002363600A1 (en) Novel phenyl-propargylether derivatives
AUPS251402A0 (en) Kinase inhibitors
AU2002341883A1 (en) 3-(heteroarylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors
AU2002336603A1 (en) 3-(heteroarylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
AU2002359458A1 (en) Alanyl-piperidine heterocyclic derivatives useful against cardiovascular diseases
AU2003230738A1 (en) Active-loop, spatially-combined amplifier
AU2002343329A1 (en) 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene)-2-indolinone derivatives as kinase inhibitors
AU2002361027A1 (en) Substituted 1,5-diaminopentan-3-ol compounds
AU2003223100A1 (en) 1,2,4-triazol-1-yl-propan-2-ol derivatives as anti-fungal agents
AU2002331281A1 (en) New uses for 2-amino-2-propane-1,3-diols